Diabetic eye disease sees advances, but questions remain
|
Despite myriad advances for the treatment of diabetic eye disease, retinal specialists still have an ongoing therapy challenge. Rishi P. Singh, MD, explains why.
|
Continue
|
|
Two drugs better than one in DME therapy?
|
Whereas most studies investigate one drug in each arm, "this approach is unique," says Charles C. Wykoff, MD, PhD. He shares more about how this combination therapy fared compared with monotherapy alone.
|
Learn more
|